Description
N-Benzyl-2-(6-bromo-2-methylquinolin-4-yloxy)acetamide (GSK124576A) is a member of the 2-(quinolin-4-yloxy)acetamide class, which has been found to inhibit growth of Mycobacterium tuberculosis, a species of pathogenic bacteria.
N-Benzyl-2-(6-bromo-2-methylquinolin-4-yloxy)acetamide
Product ID B1754
Cas No. 1443139-14-7
Purity ≥98%
| Product Unit Size | Cost | Quantity | Stock |
|---|
Product Info
| Cas No. | 1443139-14-7 |
|---|---|
| Purity | ≥98% |
| Formula | C19H17BrN2O2 |
| Formula Wt. | 385.26 |
| Chemical Name | N-benzyl-2-(6-bromo-2-methylquinolin-4-yloxy)acetamide |
| IUPAC Name | N-Benzyl-2-[(6-bromo-2-methyl-4-quinolinyl)oxy]acetamide |
| Synonym | GSK124576A |
Shipping and Storage
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
Downloads
| MSDS | |
|---|---|
| Info Sheet |
References
Phummarin N, Boshoff H, Tsang P, et al. SAR and identification of 2-(quinolin-4-yloxy)acetamides as Mycobacterium tuberculosis cytochrome bc1 inhibitors. Medchemcomm. 2016 Nov 1;7(11):2122-2127. PMID: 28337336.